Billable / Specific Code
ICD-10-CM P09.2 is the diagnosis code for Abnormal findings on neonatal screening for congenital endocrine disease. This code falls under the section "Abnormal findings on neonatal screening" within Chapter 16 — Certain conditions originating in the perinatal period (P00-P96). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Understanding where P09.2 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, P09.2 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
P09.2 is the ICD-10-CM diagnosis code for "Abnormal findings on neonatal screening for congenital endocrine disease". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of P09.2 is P09 ("Abnormal findings on neonatal screening"). P09.2 provides a more specific classification within this category.
P09.2 is located in Section P09 — "Abnormal findings on neonatal screening" within Chapter 16 of the ICD-10-CM Tabular List.
Use P09.2 when the patients documented diagnosis matches "Abnormal findings on neonatal screening for congenital endocrine disease" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Abnormal findings on neonatal screening for congenital endocrine disease is P09.2.
Yes, P09.2 can be used as a primary diagnosis code since it is billable and specific.
P09.2 is in Chapter 16 of the ICD-10-CM Tabular List.
Yes, P09.2 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.